Skip to main content

Legend Star — Portfolio

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

97
Companies
$1.0B
Total invested
$16.0M
Avg. check
32
Industries
Medical 9Health Care 8Biotechnology 6Manufacturing 6Artificial Intelligence (AI) 4Software 4+26 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 124 of 97
Oculii
September 2021

Oculii develops AI Radar Perception Software that significantly enhances ADAS today and enables full autonomous driving in the future.

Artificial Intelligence (AI) · DaytonVenture - Series Unknown
Picocom
May 2026

Picocom is a 5G open RAN baseband semiconductor and software specialist.

Infrastructure · BristolSeries C
Pharos
April 2026

Pharos is a developer of a full-stack parallel blockchain network that connects trustless Web3 developments with current FinTech services.

Blockchain · Menlo Park$44.0M Series A
Arnatar Therapeutics
April 2024

Arnatar Therapeutics is a biopharmaceutical company that specializes in the development of novel nucleic acid medications.

Biopharma · San Diego$52.0M Series A
Matternet
March 2026

Matternet makes access to goods as frictionless and universal as access to information.

Drones · Mountain View$6.0M Debt Financing
CytoTronics
September 2024

CytoTronics is designing and developing cell culture plates with embedded high-density electronic systems.

Test and Measurement · Boston$13.5M Seed
Ripcord
April 2024

Ripcord is a digital transformation company that specializes in document management processes using robotics and AI.

Artificial Intelligence (AI) · Hayward$32.0M Series C
ENSEM Therapeutics
October 2023

ENSEM Therapeutics is a biotechnology company focusing on high value and difficult-to-drug oncology targets

Biotechnology · Medford$10.0M Series A
Cargene
December 2021

Cargene is a preclinical-stage biopharmaceutical company developing oligonucleotide therapeutics across a broad range of diseases.

Biopharma · Cambridge$19.2M Seed
Carcell Biopharma
November 2023

Carcell Biopharma is a pre-clinical biotech company that promotes the development of next-generation cell and gene therapies.

Biotechnology · SingaporeSeed
Merico
October 2021

Merico develops code analytics technology to support engineering teams in understanding and optimizing productivity and code quality.

Developer Tools · San Francisco$12.4M Series A
QL Biopharma
March 2026

QL Biopharma focuses on developing innovative drugs and premium me-too drugs targeting metabolic diseases.

Biopharma · Changping$72.8M Series C
Huihe Healthcare
December 2025

Huihe Healthcare specializes in the development of medical devices for structural heart disease.

Health Care · ShanghaiSeries D
LyncBio Therapeutics
December 2025

LyncBio Therapeutics is a medical company that provides treatments, research, and toxicology studies about intestinal inflammation.

Biotechnology · Shanghai$14.3M Seed
Ubot Robotics
December 2025

Ubot Robotics is dedicated to developing leg-and-foot bionic robots.

Machine Learning · Shandong$14.1M Series A
Adaps Photonics
September 2025

Adaps Photonics is a manufacturer of high-performance photoelectric sensor chips.

Manufacturing · Shenzhen$14.0M Series C
New Cloud Medical
September 2025

New Cloud Medical is the leading pain specialist medical association

Health Care · BeijingSeries B
VelaVigo
July 2025

VelaVigo is a start-up company engaged in macromolecular biopharmaceutical.

Biopharma · Shanghai$60.0M Seed
Qingzhi
July 2025

Qingzhi is a Tianjin-based start-up developing autonomous driving technology for commercial vehicles.

Automotive · Tianjin$2.1M Series A
ZSPepLib
July 2025

ZSPepLib is a polypeptide drug developer.

Health Care · Zhuzhou$14.0M Series B
X-ORIGIN
April 2025

X-ORIGIN-AI creates consumer-grade AI companion robots, redefining human-computer interaction with emotion-driven intelligence.

Artificial Intelligence (AI) · Shenzhen$13.7M Seed
Axera
April 2025

Axera is a hight-tech semiconductor company focused on developing world class Artificial intelligence (AI) SoCs for computer applications.

AI Infrastructure · Beijing$136.1M Series C
Reforgene Medicine
December 2024

Reforgene Medicine is a biomedical company that uses gene editing and genomic technology to develop drugs intended to cure genetic diseases.

Biotechnology · GuangzhouSeries Unknown
Healingovation
May 2024

Healingovation is a med-tech company that specializes in the development of surgical robots, intelligent diagnosis and treatment equipment.

Manufacturing · Daxing$8.3M Seed

Where Legend Star invests

Medical9
Health Care8
Biotechnology6
Manufacturing6
Artificial Intelligence (AI)4
Software4

About Legend Star's portfolio

How many companies has Legend Star invested in?

Legend Star has invested in 97 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Legend Star invest in?

Legend Star's top investment sectors include Medical, Health Care, Biotechnology, Manufacturing, Artificial Intelligence (AI). The firm invests across 32 different industry categories.

What is Legend Star's largest investment?

Among tracked funding rounds, Axera received $136.1M in a Series C round. Legend Star's total known invested capital is $1.0B.

What is the average investment size for Legend Star?

Legend Star's average investment size is $16.0M across its portfolio of 97 companies.

What are Legend Star's most recent investments?

Recent Legend Star portfolio additions include Oculii, Picocom, Pharos, Arnatar Therapeutics, Matternet. These companies were founded in 2020 or later.

Reach the founders behind these 97 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →